By inhibiting Rac1 activity and suppressing the corresponding downstream effects, such as F-actin polymerization and VEGF expression, TIPE2 functions as a tumor suppressor to control the migration, invasion of NSCLC cells and the angiogenesis in tumor microenvironment. The gene discussed is VEGFA; the disease is neoplasm.